ArticleCancer medicine2024

Individualized Prediction for Risk of Recurrence in Stage I/II Melanoma Patients With Negative Sentinel Lymph Node.

Shu-Ching Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.